scAAV9-CBh-mCherry

The scAAV9-CBh-mCherry vector is a cutting-edge tool in the field of gene delivery, combining the advantages of self-complementary adeno-associated virus (scAAV) technology with the superior tissue tropism of serotype 9 virus. This system eliminates the need for second-strand DNA synthesis, enabling faster and stronger transgene expression compared to traditional single-stranded AAV vectors. The CBh promoter drives robust and widespread expression of the mCherry fluorescent protein in various cell types. The AAV9 serotype exhibits excellent central nervous system penetration and broad tissue transduction capabilities, including efficient crossing of the blood-brain barrier. The self-complementary design provides higher transduction efficiency at lower viral titers, while the excellent photostability and extremely low cytotoxicity of mCherry make it ideal for long-term tracking studies. This vector system maintains the inherent safety of AAV, with low immunogenicity and persistent episomal expression.

The scAAV9-CBh-mCherry vector is a powerful tool for a variety of research applications. In neuroscience, its superior neurotropism allows for high-resolution imaging of neural circuits and axonal projections. The bright mCherry signal facilitates live-cell imaging, flow cytometry analysis, and tissue clearing techniques. Cardiovascular researchers utilize this system to study cardiomyocyte transduction and cardiac gene therapy approaches. Its ability to cross the blood-brain barrier makes it invaluable for constructing models of neurological diseases and testing gene therapy strategies for conditions such as Parkinson''s disease or lysosomal storage disorders. Developmental biologists use this vector for cell fate tracking studies, while stem cell researchers employ it to track transplanted cells. This vector also serves as an excellent positive control for evaluating transduction efficiency and comparing promoter activity.